Editorial: sofosbuvir plus daclatasvir for the treatment of hepatitis C-can one size fit all?

被引：0

作者：

Sun, J. ^{[1
]}

Liang, X.

Fan, R.

Hou, J.

机构：

[1] Southern Med Univ, State Key Lab Organ Failure Res, Guangdong Prov Key Lab Viral Hepatitis Res, Dept Infect Dis,Nanfang Hosp, Guangzhou, Guangdong, Peoples R China

来源：

ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2018年 / 47卷 / 06期

关键词：

D O I：

10.1111/apt.14530

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：853 / 854

页数：2

共 8 条

[1] Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus [J].

Chung, Raymond T. ;

Davis, Gary L. ;

Jensen, Donald M. ;

Masur, Henry ;

Saag, Michael S. ;

Thomas, David L. ;

Aronsohn, Andrew I. ;

Charlton, Michael R. ;

Feld, Jordan J. ;

Fontana, Robert J. ;

Ghany, Marc G. ;

Godofsky, Eliot W. ;

Graham, Camilla S. ;

Kim, Arthur Y. ;

Kiser, Jennifer J. ;

Kottilil, Shyam ;

Marks, Kristen M. ;

Martin, Paul ;

Mitruka, Kiren ;

Morgan, Timothy R. ;

Naggie, Susanna ;

Raymond, Daniel ;

Reau, Nancy S. ;

Schooley, Robert T. ;

Sherman, Kenneth E. ;

Sulkowski, Mark S. ;

Vargas, Hugo E. ;

Ward, John W. ;

Wyles, David L. .

HEPATOLOGY, 2015, 62 (03) :932-954

[2] Sofosbuvir plus daclatasvir with or without ribavirin in 551 patients with hepatitis C-related cirrhosis, genotype 4 [J].

El-Khayat, H. ;

Fouad, Y. ;

Mohamed, H. I. ;

El-Amin, H. ;

Kamal, E. M. ;

Maher, M. ;

Risk, A. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (05) :674-679

[3] Reply to "Association between IL28B polymorphism and treatment response in patients with genotype 4 chronic hepatitis C" [J].

Estrabaud, Emilie ;

Lada, Olivier ;

Asselah, Tarik .

JOURNAL OF HEPATOLOGY, 2012, 57 (03) :706-707

[4] EASL Recommendations on Treatment of Hepatitis C 2016 [J].

European Association for the Study of the Liver easloffice@easloffice.eu .

JOURNAL OF HEPATOLOGY, 2017, 66 (01) :153-194

[5] Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect [J].

Gao, Min ;

Nettles, Richard E. ;

Belema, Makonen ;

Snyder, Lawrence B. ;

Nguyen, Van N. ;

Fridell, Robert A. ;

Serrano-Wu, Michael H. ;

Langley, David R. ;

Sun, Jin-Hua ;

O'Boyle, Donald R. ;

Lemm, Julie A. ;

Wang, Chunfu ;

Knipe, Jay O. ;

Chien, Caly ;

Colonno, Richard J. ;

Grasela, Dennis M. ;

Meanwell, Nicholas A. ;

Hamann, Lawrence G. .

NATURE, 2010, 465 (7294) :96-U108

[6] Hepatitis C therapy with HCV NS5B polymerase inhibitors [J].

Soriano, Vincent ;

Vispo, Eugenia ;

de Mendoza, Carmen ;

Labarga, Pablo ;

Vicente Fernandez-Montero, Jose ;

Poveda, Eva ;

Trevino, Ana ;

Barreiro, Pablo .

EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (09) :1161-1170

[7]

Sulkowski MS, 2014, NEW ENGL J MED, V370, P1560, DOI 10.1056/NEJMc1401726

[8]

WHO Guidelines Approved by the Guidelines Review Committee, 2016, THESIS U MELBOURNE M

← 1 →